ADEASY SYSTEM
ANDROGEN RECEPTOR
ANDROGEN RECEPTOR
AR-DEPENDENT MANNER
AS3
AS3
AS3 OVEREXPRESSION MIMIC
ANDROGEN-MEDIATED CELL CYCLE ARREST AS3 OVEREXPRESSION MIMIC
ATCC
ATP
ATP
ATP
ATP-DEPENDENT ACTIVATION
UBIQUITIN ATP-DEPENDENT ACTIVATION
AB-1
AB-2
AB-6
ABBREVIATION
AD-SKP2
AD-SKP2
AD-SKP2
AD-SKP2-ΔF
AD-SKP2-ΔF
AD-SKP2-ΔF
ADENOVIRAL DNA
ADENOVIRUS
ADOBE PHOTOSHOP
ALIQUOT
PHOSPHORYLATED PROTEIN ALIQUOT
AMERSHAM HYBOND N
AMPLIFIED VIRUS
ANDROGEN CONTROL
LNCAP CELL PROLIFERATION ANDROGEN CONTROL
ANDROGEN-INDUCED G1 ARREST
ANTIBODY
B-SKP2
B. VOGELSTEIN
BJ-ADEASY CELL
BJ-ADEASY CELL
BIOCHEMICAL STUDY
C-TERMINAL LEUCINE-RICH REPEAT
C. SONNENSCHEIN
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CDK2
CDK2
CDK2
CDK2
CDK2
CDK2 ACTIVATION
CDK2 ACTIVATION
CDK2 ACTIVATION
CDK2 ACTIVITY
CDK2 ACTIVITY
CDK2 COMPLEX
CDK2 COMPLEX
CDK2 COMPLEX
CDK2 INHIBITION
CDK2 INHIBITOR P27
CDK2 KINASE ACTIVITY
CDK2 KINASE ACTIVITY
CDK2 KINASE ACTIVITY ASSAYED
CDK
CHX
CKS1
COP9
COP9
CRL-10995
CSN5
CSN5
CSN5
CSN5
CSN5
CSN5
CSN5
CULLIN 1
CULLIN 1
CULLIN 1
CULLIN 1
CELL LYSATE
CELL LYSATE
CELL LYSATE
IMMUNOPRECIPITATION CELL LYSATE
COMPLEMENTARY DNA FRAGMENT
SKP2 COMPLEMENTARY DNA FRAGMENT
COVERSLIP
CULLIN/F-BOX PROTEIN COMPLEX UBC
CYCLIN
DHT-TREATED CELL
DEMARZO
E COMPLEX
E3 UBIQUITIN LIGASE
F-BOX
F-BOX
F-BOX
F-BOX
F-BOX
F-BOX DEPENDENCY
F-BOX-DEPENDENT P27
FETAL BOVINE SERUM
G BEAD
G1 ARREST
G1 ARREST
G1 ARREST
GLYCERALDEHYDE 3 PHOSPHATE           DEHYDROGENASE
GAPDH PROBE
GENETEX MS-JAB11-PX1
GLEASON SCORE
H.S
HRT1
HRT1
HRT1
IP-LB
IP-LB
IP-LB
IMMOBILON P MEMBRANE
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOCOMPLEX
IMMUNOLOGICAL TECHNIQUE
CELL LYSATE IMMUNOLOGICAL TECHNIQUE
INFECTION
ASYNCHRONOUS LNCAP CELL INFECTION
JAB1
JAB1
JAB1
L-F
LNCAP CELL LYSATE
LNCAP CELL LYSATE
LNCAP CELL LYSATE
LNCAP CELL PROLIFERATION
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP M RNA
LYSATE
MCF7 CELL
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
CAUSED ARREST MITOCHONDRIA           ISOLATION BUFFER
INDUCED INHIBITION MITOCHONDRIA           ISOLATION BUFFER
MIB-ARRESTED LNCAP CELL
MIB-ARRESTED CELL
MIB-ARRESTED CELL
MIB-EXPOSED CELL
MIB-INDUCED G1 CELL CYCLE ARREST
MIB-INDUCED G1 CELL CYCLE ARREST
MIB-INDUCED RB1 DOWNREGULATION
MIB-INDUCED CELL CYCLE ARREST
MIB-INDUCED P27
MIB-INDUCED P27 UPREGULATION
MIB-TREATED LNCAP CELL
MIB-TREATED CELL
MIB-TREATED CELL
MS-1061
MS-870
MGCL
MIBOLERONE
MICROGRAPH
MILLIPORE
N-TERMINAL MYC EPITOPE TAG
NEOMARKER
NEOMARKER
NEOMARKER
AB-1 NEOMARKER
AB-2 NEOMARKER
AB-6 NEOMARKER
NIKON E600 EPIFLUORESCENCE MICROSCOPE
NORTHERN BLOTTING ISOLATION
TOTAL CELLULAR RNA NORTHERN BLOTTING ISOLATION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PCR
PCR
PCR
PCR
PTEN
PERKIN ELMER LIFE SCIENCE
PHARMINGEN
POLYUBIQUITYLATION
WILDTYPE POLYUBIQUITYLATION
PROTEIN SYNTHESIS
QUICKCHANGE
RB-012
RB1
RB1
RB1
RB1 PHOSPHORYLATION
RB1 SUPPRESSION
RBX1
ROC1
RPMI SUPPLEMENTED
RADIOLABELED WILDTYPE
RE-ADMINISTRATION
ANDROGEN RE-ADMINISTRATION
RECENT STUDY
RECOMBINANT ADENOVIRAL DNA
S PHASE
S PHASE
S PHASE
S PHASE
S PHASE
S PHASE ENTRY
S PHASE ENTRY
S PHASE ENTRY
S PHASE ENTRY
SCF
SCF
SCF
SCF
SCF
SD
SD
SD
SD
SD
GEL ELECTROPHORESI SD
GEL ELECTROPHORESI SD
GEL ELECTROPHORESI SD
SDS SAMPLE BUFFER
SDS SAMPLE BUFFER
SKP
SKP-ΔF
SKP1
SKP1
SKP1
SKP1
SKP1
SKP1
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2-INDUCED UPREGULATION
SKP2-MEDIATED P27 DEGRADATION
SKP2-MEDIATED P27 DOWNREGULATION
SKP2-ΔF
SKP2-ΔF MUTANT
SKP2-ΔF OVEREXPRESSING CELL
SSC
SSC
SSC
SANTA CRUZ SC-7164
SANTO CRUZ BIOTECHNOLOGY SC-163
SIGMA
SIMULTANEOUS ADMINISTRATION
MITOCHONDRIA           ISOLATION BUFFER SIMULTANEOUS ADMINISTRATION
STRATAGENE
TISSUE CULTURE LNCAP-FGC CELL
TRANSDUCTION LABORATORY
TRITON X100
TRITON X100
TRITON X100
TRITON X100
TUBULIN
TWEEN
U87 CELL
U87 CELL
U87 CELL
UBC3
UBIQUITIN
CONJUGATING ENZYME MIB UBIQUITIN
UBIQUITYLATION SUBSTRATE
X-RAY FILM
ZYMED
ZYMED
ACCUMULATION
ACCUMULATION
ACCUMULATION
ACCUMULATION
ACCUMULATION
P27 ACCUMULATION
P27 PROTEIN ACCUMULATION
ADDITION
ADDITION
ADDITION
ADDITION
ADDITION
ADDITION
ADDITION
SD ADDITION
SAMPLE BUFFER SD ADDITION
ADENOVIRUS
ADENOVIRUS
AFFINITY-PURIFIED RABBIT POLYCLONAL
AGGRESSIVE PROSTATE CANCER
ALANINE
ANDROGEN
ANDROGEN
ANDROGEN
ANDROGEN
ANDROGEN ACTIVITY
ANDROGEN ADMINISTRATION
ANDROGEN ADMINISTRATION
ANDROGEN CONTROL
ANDROGEN CONTROL
P27 EXPRESSION ANDROGEN CONTROL
ANDROGEN DIHYDROTESTOSTERONE
ANDROGEN LEVEL
ANDROGEN RECEPTOR
ANDROGEN RESPONSE MECHANISM
LNCAP CELL ANDROGEN RESPONSE MECHANISM
ANDROGEN-INDUCED G1 ARREST
ANDROGEN-INDUCED GROWTH ARREST
ANDROGEN-INDUCED P27 UPREGULATION
ANDROGEN-MEDIATED G1 ARREST
ANDROGEN-MEDIATED CELL CYCLE ARREST
ANDROGEN-MEDIATED CELL CYCLE CONTROL
ANDROGEN-MEDIATED CELL CYCLE CONTROL
ANDROGEN-MEDIATED GROWTH CONTROL
ANDROGEN-MEDIATED P27 ACCUMULATION
ANDROGEN-MEDIATED P27 ACCUMULATION
ANDROGEN-MEDIATED P27 CONTROL
ANDROGEN-SENSITIVE
ANDROGEN
ANEUPLOID DERIVATIVE
METASTATIC LESION ANEUPLOID DERIVATIVE
ANTI-SENSE AS3
ANTIANDROGEN CYPROTERONE ACETATE
ANTIANDROGEN CYPROTERONE ACETATE
ANTIBODY
ANTIBODY
ANTIBODY INCUBATION
APOPTOSIS-INDUCING ACTIVITY
ASSAY
ASSOCIATED PROTEIN
ASYNCHRONOUS LNCAP CELL
AUTORADIOGRAPHY
AUTORADIOGRAPHY
BACULOVIRUS
BUFFER
CALCIUM PHOSPHATE PROCEDURE
CANCER CELL LINE
CANCER CELL
CASTRATION LEAD
CAUSED ARREST
CELL CYCLE
CELL CYCLE EXIT
CELL CYCLE-DEPENDENT VARIATION
CELL LINE LNCAP
CELL LYSATE
CELL LYSATE
CELL LYSATE
CENTRIFUGATION
CENTRIFUGATION
CESIUM CHLORIDE GRADIENT CENTRIFUGATION
CHARACTERISTIC BIPHASIC RESPONSE
CIRCUMSTANTIAL EVIDENCE
CM FALCON
CO-EXPRESSION
CYCLIN CO-EXPRESSION
CONCENTRATION
CONCENTRATION
CONJECTURE
CONJUGATING ENZYME
CONJUGATING ENZYME MIB
CONSOLIDATION EFFECT
CONTINUOUS PRESENCE
CONTINUOUS PRESENCE
MITOCHONDRIA           ISOLATION BUFFER CONTINUOUS PRESENCE
ANDROGEN CONTINUOUS PRESENCE
CONTRIBUTION
CONTROL CELL
CONTROL CELL
CONTROL LEVEL
COORDINATION
COVERSLIP
CREATINE PHOSPHATE
CRITICAL CDK2 PHOSPHORYLATION SITE
CYCLIN
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E COMPLEX
CYCLIN E KINASE ACTIVITY
CYCLIN E LEVEL
CYCLIN E LEVEL
CYCLIN E-ASSOCIATED H1 KINASE ACTIVITY
CYCLIN-DEPENDENT KINASE
CYCLIN-DEPENDENT KINASE
CYCLIN
CYCLOHEXIMIDE
CYTOTOXIC
DECREASED P27 PROTEIN LEVEL
DEMONSTRATED SKP2-INDEPENDENT PROTEOLYSI
P27 DEMONSTRATED SKP2-INDEPENDENT PROTEOLYSI
DEPHOSPHORYLATED STATE
DETERMINANT
DETERMINANT
P27 DEGRADATION DETERMINANT
P27 LEVEL DETERMINANT
DIFFERENTIATION
DOWN-REGULATION
P27 DOWN-REGULATION
DOWNREGULATE P27 LEVEL
DOWNREGULATION
DOWNREGULATION
DOWNREGULATION
CYCLIN-DEPENDENT KINASE DOWNREGULATION
ECTOPIC DEGRADATION
ECTOPIC PROTEOLYSI
ELECTROPORATION
ENABLING ESCAPE
ENZYMATIC REACTION
EPITHELIAL CELL PROLIFERATION
ETHANOL
EXCLUSIVE
EXPRESSING EXOGENOUS AR
FINAL MANUSCRIPT
FIXED
FLOW CYTOMETRY
FLOW CYTOMETRY
FOUR-FOLD
FRACTION
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GENE INDUCED
GLANDULAR STRUCTURE
GLASS COVERSLIP
GROWTH INHIBITING LEVEL
ANDROGEN GROWTH INHIBITING LEVEL
GROWTH INHIBITION
H COURSE
H. CELL
HISTONE
HOMOZYGOUS INACTIVATION
HYPOPHOSPHORYLATED STATE
HYPOTONIC LYSI
HYPOTONIC LYSI
IDENTIFIED ANDROGEN-MEDIATED PATHWAY
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOFLUORESCENCE STAINING
IMMUNOFLUORESCENCE STAINING
IMMUNOFLUORESCENCE STAINING
IMMUNOFLUORESCENCE STAINING
IMMUNOPRECIPITATION
IMMUNOPRECIPITATION
IMMUNOPRECIPITATION
IN VITRO ASSAY
IN VITRO STUDY
IN VITRO TRANSCRIPTION
IN VITRO TRANSCRIPTION
IN VITRO TRANSCRIPTION
INACTIVATION
INCREASED P27 UBIQUITYLATION ACTIVITY
INDIVIDUAL CELL
INDUCED INHIBITION
INDUCTION
INFECTION
INFECTION
INFECTION
INFECTION
INHIBITION CORRELATED
INHIBITOR P27
INTEGRAL COMPONENT
ANDROGEN-MEDIATED GROWTH CONTROL INTEGRAL COMPONENT
LNCAP CELL ANDROGEN-MEDIATED GROWTH CONTROL INTEGRAL COMPONENT
INTERPRETATION
INTERVENTION
INVASIVE CARCINOMA
INVERSE CORRELATION
LACKING CSN SUBUNIT
LAMIN B LEADER SEQUENCE
MM ATP
MM ATP
MM DTT
MM HEPE
PH MM HEPE
MM KCL
MM NACL
MM PMSF
MM PMSF
MM TRI
METASTATIC LESION
MG/ML UBIQUITIN
MIBOLERONE
MICROSCOPY SLIDE
MIN
MIN
MIN
MIN
MIN
MODEL SYSTEM
MOLAR EXCESS
ANTIANDROGEN CYPROTERONE ACETATE MOLAR EXCESS
MORPHOLOGICAL GLAND INTEGRITY
MUTANT
MUTANT
MUTANT SKP2-ΔF
MUTANT P27
NEGATIVE CONTROL
NORMAL ANDROGEN CONTROL
NORMAL BIPHASIC MECHANISM
ANDROGEN CONTROL NORMAL BIPHASIC MECHANISM
NORMAL HUMAN PROSTATE
NUCLEUS
OBSERVATION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
PTEN OVEREXPRESSION
SKP-ΔF OVEREXPRESSION
SKP2 OVEREXPRESSION
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27 RNA LEVEL
P27 ABUNDANCE
P27 ACCUMULATION
P27 ACCUMULATION RESULT
P27 DEGRADATION
P27 DEGRADATION
P27 DEGRADATION
P27 DEPLETION
P27 DEPLETION
P27 DOWN-REGULATION
P27 DOWNREGULATION
P27 DOWNREGULATION
P27 EXPORT
P27 EXPRESSION
P27 EXPRESSION
P27 EXPRESSION
P27 GENE
P27 HALF-LIFE
P27 HALF-LIFE
P27 HALF-LIFE
P27 INACTIVATION
P27 LEVEL
P27 LEVEL
P27 LEVEL
P27 LEVEL
P27 LEVEL
P27 MRNA
P27 MRNA
P27 MRNA LEVEL
P27 PHOSPHORYLATION
P27 PHOSPHORYLATION
P27 PROTEIN
P27 PROTEIN
P27 PROTEIN LEVEL
P27 PROTEIN STABILITY
P27 PROTEOLYSI
P27 REGULATION
P27 REGULATION
P27 STABILIZATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION ACTIVITY
P27 UPREGULATION
P27 UPREGULATION
P27 UPREGULATION
P27 UPREGULATION
P27 UPREGULATION
PADTRACK1 SHUTTLE VECTOR
PH
PARA-FORMALDEHYDE
PCDNA3
PCDNA3 ENABLING
IN VITRO TRANSCRIPTION PCDNA3 ENABLING
PELVIC LYMPH NODE
PHENOTYPE
LNCAP CELL PHENOTYPE
PHOSPHOIMAGER
SIGNAL QUANTITATION PHOSPHOIMAGER
PHOSPHORYLATED PROTEIN
PHOSPHORYLATION
P27 PHOSPHORYLATION
PLASMID
POINT MUTANT
P27 POINT MUTANT
POLY-LYSINE
POLYUBIQUITYLATED HIGH MOLECULAR WEIGHT SPECIES
POSTMITOTIC DIFFERENTIATION
POTENTIAL TARGET
POTENTIAL TARGET
INTERVENTION POTENTIAL TARGET
THERAPEUTIC INTERVENTION POTENTIAL TARGET
POTENTIAL TRANSCRIPTION FACTOR
PRE-CASTRATION CELL NUMBER
PREVENTED P27 ACCUMULATION
PRIMARY CANCER SPECIMEN
PRIMARY RAT HEPATOCYTE
PROGNOSTIC MORPHOLOGICAL FEATURE
PROLIFERATING CELL
PROLIFERATION
PROLIFERATION
PROLIFERATION
PROLIFERATION
PROMOTING S PHASE ENTRY
MIB-ARRESTED LNCAP CELL PROMOTING S PHASE ENTRY
PROSTATE
PROSTATE
PROSTATE CANCER
PROSTATE CANCER
PROSTATE CANCER CELL LINE LNCAP
PROSTATE CANCER CELL
PROSTATE CANCER CELL
PROSTATE CANCER
PROSTATE CANCER
EPITHELIAL CELL PROLIFERATION PROSTATE
PROSTATE TUMOR SUPPRESSOR
PROSTATIC INTRAEPITHELIAL NEOPLASIA
PROTEASOME
PROTEIN
PROTEIN
PROTEIN
PROTEIN
PROTEIN LEVEL
PROTEIN STABILITY
PROTEOLYSI
PROTEOLYTIC DOWNREGULATION
P27 PROTEOLYTIC DOWNREGULATION
PROXIMAL ELEMENT
RABBIT RETICULOCYTE LYSATE
RA
RAT FIBROBLAST
RAT FIBROBLAST
RAT FIBROBLAST
REACTION PRODUCT
RECOMBINATION
RESULTING PLASMID
REVERSE TRANSCRIPTION
SAMPLE BUFFER
SECONDARY ANTIBODY
SECRETORY CELL
SERUM
STARVED RAT FIBROBLAST SERUM
SHOWED DOWN-REGULATION
P27 SHOWED DOWN-REGULATION
SIGNAL QUANTITATION
SIGNALOSOME
SIGNALOSOME SUBUNIT CSN5
SOLUTION
STARVED RAT FIBROBLAST
STATE RNA LEVEL
STEADY-STATE P27 PROTEIN LEVEL
STIMULATING CDK2 ACTIVITY
STIMULATING CELL
SUBUNIT
COP9 SUBUNIT
SUPERNATANT
SYNTHETIC ANDROGEN
SYNTHETIC ANDROGEN MIBOLERONE
TARGET PROTEIN
THERAPEUTIC INTERVENTION
THREONINE
TIME POINT
TIME-DEPENDENT ACCUMULATION
TIME-DEPENDENT DOWNREGULATION
P27 TIME-DEPENDENT DOWNREGULATION
TIME-DEPENDENT INCREASE
TISSUE-SPECIFIC REGULATION
TOTAL CELLULAR RNA
TRANSCRIPTIONAL TARGET
ANDROGEN RECEPTOR TRANSCRIPTIONAL TARGET
TRANSFORMATION
TRANSIENT EPITHELIAL CELL PROLIFERATION
TRIS-BUFFERED SALINE
TUBULIN
TUBULIN LEVEL
TUMOR SUPPRESSOR
TURN BIND
TWO-FOLD
UBIQUITIN
UBIQUITIN
UBIQUITIN
UBIQUITIN
UBIQUITIN CHAIN
CONJUGATING ENZYME UBIQUITIN
UBIQUITIN TRANSFER REACTION
UBIQUITIN-CONJUGATING ENZYME CDC34
UBIQUITIN/PROTEASOME SYSTEM
UBIQUITYLATION
UBIQUITYLATION
UBIQUITYLATION NORTHERN BLOT ANALYSIS
UBIQUITYLATION ASSAY
UG
UG
UNDERPHOSPHORYLATED FORM
UPREGULATION
UPREGULATION
P27 UPREGULATION
UREA/LICL PROTOCOL
VIRAL ONCOPROTEIN
VITROUBIQUITYLATION ASSAY CELL LYSATE
UBIQUITYLATION ASSAY VITROUBIQUITYLATION ASSAY CELL LYSATE
WILDTYPE
ΜM MG132
ΜM OKADAIC ACID
ΜM UBIQUITIN ALDEHYDE
ΜG CELL LYSATE
ΜG/ML
ΜG/ML APROTININ
ΜG/ML CREATINE KINASE
ΜG/ML LEUPEPTIN
ΜG/ML LEUPEPTIN
ΜG/ML PEPSTATIN
ΜG/ML PEPSTATIN
CDK
UBIQUITIN CONJUGATING
UBC
DIHYDROTESTOSTERONE
DHT
CYPROTERONE ACETATE
CA
AR
COP9/SIGNALOSOME
CSN
MANNER
AS3 OVEREXPRESSION
OVEREXPRESSION
activation
DNA
PHOTOSHOP
HYBOND N
ANDROGEN
controls
ANDROGEN-INDUCED
G1 ARREST
G1
VOGELSTEIN
C-TERMINAL LEUCINE-RICH
LEUCINE-RICH
SONNENSCHEIN
activation
activation
activation
inhibition
INHIBITOR P27
kinase activity
kinase activity
CDK2 KINASE ACTIVITY
LYSATE
COMPLEMENTARY DNA
DNA
PROTEIN COMPLEX UBC
COMPLEX UBC
DHT-TREATED
ubiquitin ligases
UBIQUITIN
F-BOX
dependencies
P27
ARREST
ARREST
ARREST
probes
MS-JAB11-PX1
PS
LNCAP CELL
CELL LYSATE
LNCAP CELL
CELL LYSATE
LNCAP CELL
CELL LYSATE
LNCAP CELL
CELL PROLIFERATION
M RNA
MIB-ARRESTED
MIB-ARRESTED
MIB-EXPOSED
MIB-INDUCED
G1 CELL CYCLE ARREST
CELL CYCLE ARREST
G1
MIB-INDUCED
G1 CELL CYCLE ARREST
CELL CYCLE ARREST
G1
MIB-INDUCED
RB1 DOWNREGULATION
RB1
MIB-INDUCED
CELL CYCLE ARREST
CYCLE ARREST
MIB-INDUCED
P27
MIB-INDUCED P27
MIB-INDUCED
P27 UPREGULATION
P27
MIB-TREATED
MIB-TREATED
MYC EPITOPE TAG
epitope tags
E600 EPIFLUORESCENCE MICROSCOPE
BLOTTING ISOLATION
PERKIN ELMER LIFE
synthesis
PHOSPHORYLATION
SUPPRESSION
WILDTYPE
ADENOVIRAL DNA
PHASE ENTRY
PHASE ENTRY
PHASE ENTRY
PHASE ENTRY
SAMPLE BUFFER
SAMPLE BUFFER
UPREGULATION
SKP2-MEDIATED P27
P27 DEGRADATION
P27
SKP2-MEDIATED P27
P27 DOWNREGULATION
P27
MUTANT
SKP2-ΔF OVEREXPRESSING
OVEREXPRESSING
administration
TRANSDUCTION
X100
X100
X100
X100
films
RABBIT POLYCLONAL
AGGRESSIVE PROSTATE
administration
administration
controls
controls
DIHYDROTESTOSTERONE
receptors
ANDROGEN-INDUCED
G1 ARREST
G1
ANDROGEN-INDUCED
growth arrest
ANDROGEN-INDUCED
P27 UPREGULATION
P27
ANDROGEN-MEDIATED
G1 ARREST
G1
ANDROGEN-MEDIATED
CELL CYCLE ARREST
CYCLE ARREST
ANDROGEN-MEDIATED
CELL CYCLE CONTROL
CYCLE CONTROL
ANDROGEN-MEDIATED
CELL CYCLE CONTROL
CYCLE CONTROL
ANDROGEN-MEDIATED
GROWTH CONTROL
ANDROGEN-MEDIATED P27
ANDROGEN-MEDIATED
P27 ACCUMULATION
P27
ANDROGEN-MEDIATED P27
ANDROGEN-MEDIATED
P27 ACCUMULATION
P27
ANDROGEN-MEDIATED P27
ANDROGEN-MEDIATED
P27 CONTROL
P27
AS3
CASTRATION
ARREST
CYCLE EXIT
cell lines
LINE LNCAP
LYSATE
CHLORIDE GRADIENT CENTRIFUGATION
GRADIENT CENTRIFUGATION
BIPHASIC RESPONSE
EVIDENCE
ENZYME MIB
effects
PRESENCE
PRESENCE
controls
controls
controls
CDK2 PHOSPHORYLATION SITE
CDK2
ES
ES
ES
ES
ES
ES
ES
CYCLIN E
ES
CYCLIN E
ES
kinase
CYCLIN E
ES
CYCLIN E
ES
CYCLIN
kinase
kinase
kinase
P27
DEMONSTRATED SKP2-INDEPENDENT
SKP2-INDEPENDENT
DOWNREGULATE P27
downregulates
P27
degradation
ESCAPE
epithelial cells
CELL PROLIFERATION
EXOGENOUS AR
cytometry
cytometry
genes
growth
growth
inhibition
COURSE
INACTIVATION
LYSIS
LYSIS
ANDROGEN-MEDIATED PATHWAY
ANDROGEN-MEDIATED
P27 UBIQUITYLATION ACTIVITY
P27
inhibition
inhibition
inhibitors
P27
carcinomas
correlations
LACKING CSN
CSN
B
ATP
ATP
DTT
KCL
NACL
PMSF
PMSF
TRIS
lesions
mg/ml
UBIQUITIN
EXCESS
P27
controls
ANDROGEN CONTROL
BIPHASIC MECHANISM
P27 RNA
P27
RNA
P27
P27
ACCUMULATION
P27 ACCUMULATION
P27
P27
degradation
P27
degradation
P27
degradation
P27
DEPLETION
P27
DEPLETION
P27
DOWNREGULATION
DOWNREGULATION
P27
EXPORT
P27
expressions
P27
expressions
P27
expressions
genes
P27
P27
P27
P27
INACTIVATION
P27
P27
P27
P27
P27
P27
MRNA
P27
MRNA
P27
PHOSPHORYLATION
P27
PHOSPHORYLATION
P27
P27
P27
P27
REGULATION
P27
REGULATION
P27
stabilization
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
UBIQUITYLATION ACTIVITY
P27
UPREGULATION
P27
UPREGULATION
P27
UPREGULATION
P27
UPREGULATION
P27
UPREGULATION
PCDNA3
MUTANT
DIFFERENTIATION
targets
targets
transcription factors
P27 ACCUMULATION
P27
PRIMARY CANCER
primary rat
S PHASE ENTRY
PHASE ENTRY
SS
CANCER CELL LINE LNCAP
CELL LINE LNCAP
TUMOR SUPPRESSOR
INTRAEPITHELIAL NEOPLASIA
DOWNREGULATION
RETICULOCYTE LYSATE
reactions
PLASMID
transcription
BUFFER
signals
quantitation
SIGNALOSOME
SUBUNIT CSN5
SUBUNIT
STATE RNA
RNA
P27
CDK2
ANDROGEN MIBOLERONE
targets
INTERVENTION
times
ACCUMULATION
DOWNREGULATION
increases
REGULATION
CELLULAR RNA
targets
EPITHELIAL CELL PROLIFERATION
CELL PROLIFERATION
epithelial
TURN
TRANSFER REACTION
ENZYME CDC34
NORTHERN BLOT ANALYSIS
blot analyses
protocols
MG132
okadaic acid
UBIQUITIN ALDEHYDE
CELL LYSATE
ΜG/ML
aprotinin
ΜG/ML
CREATINE KINASE
CREATINE
ΜG/ML
leupeptin
ΜG/ML
leupeptin
ΜG/ML
pepstatin
ΜG/ML
pepstatin
